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Abstract
Background: Two studies were conducted to evaluate and compare the efficacy of imidacloprid + moxidectin and
selamectin topical solutions against the KS1 flea strain infesting cats. In both studies the treatment groups were
comprised of non-treated controls, 6% w/v selamectin (Revolution
®; Pfizer Animal Health) topical solution and 10%
w/v imidacloprid + 1% w/v moxidectin (Advantage Multi
® for Cats, Bayer Animal Health) topical solution. All cats
were infested with 100 fleas on Days -2, 7, 14, 21, and 28. The difference in the studies was that in study #1
efficacy evaluations were conducted at 24 and 48 hours post-treatment or post-infestation, and in study #2
evaluations were conducted at 12 and 24 hours.
Results: In study #1 imidacloprid + moxidectin and the selamectin formulation provided 99.8% and 99.0% efficacy
at 24 hours post-treatment. On day 28, the 24 hour efficacy of the selamectin formulation dropped to 87.1%,
whereas the imidacloprid + moxidectin formulation provided 98.9% efficacy. At the 48 hour assessments following
the 28 day infestations, efficacy of the imidacloprid + moxidectin and selamectin formulations was 96.8% and
98.3% respectively. In study # 2 the efficacy of the imidacloprid + moxidectin and selamectin formulations 12 hours
after treatment was 100% and 69.4%, respectively. On day 28, efficacy of the imidacloprid + moxidectin and
selamectin formulations 12 hours after infestation was 90.2% and 57.3%, respectively. In study #2 both formulations
provided high levels of efficacy at the 24 hour post-infestation assessments, with selamectin and imidacloprid +
moxidectin providing 95.3% and 97.5% efficacy, following infestations on day 28.
Conclusions: At the 24 and 48 hour residual efficacy assessments, the imidacloprid + moxidectin and selamectin
formulations were similarly highly efficacious. However, the imidacloprid + moxidectin formulation provided a
significantly higher rate of flea kill against the KS1 flea strain infesting cats at every 12 hour post-infestation residual
efficacy assessment. Both formulations should provide excellent flea control for an entire month on cats.
Background
Numerous animals that travel through neighborhoods,
parks and yards carry Ctenocephalides felis (cat fleas),
including feral cats and wildlife, such as opossums, rac-
coons, foxes, and coyotes [1]. These flea-infested ani-
mals are continuously depositing flea eggs in the
outdoor environment. Within a few weeks, eggs depos-
ited in protected areas may develop into adult fleas. If
pets come in contact with these areas, they can rapidly
acquire fleas. Once on a pet, the fleas will feed and
mate, after which female fleas will begin laying eggs
within as little as 24 hours [2]. After a few days, each
female flea will produce 40 to 50 eggs per day, with
hundreds and potentially thousands of eggs being depos-
ited back in the home [3].
Most pet owners never see the first two or three fleas
their pets acquire and pets often go without flea preven-
tive treatment for several days or weeks [4]. During that
time, flea eggs are continually deposited in the home,
with development of larvae, pupae, and eventually emer-
ging adult fleas. At some point, there are enough fleas
emerging within the home and on the pet that the pro-
blem becomes noticeable by the owner. But by that
time, the home is already infested with hundreds to
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emerge as adults to continually reinfest the pet [4,5].
When the flea infested pet is presented to a veterinarian,
the resident flea population on the pet must be eliminated
rapidly, but control of the infestation is ultimately achieved
by eliminating the existing immature and mature flea life
stages within the premises. As fleas emerge and jump on
pets, it is critical to kill them as rapidly as possible. The
more rapidly a residual flea product can kill newly
acquired fleas, the more effectively it can manage flea
allergy dermatitis, the more likely it can decrease the
transmission of vector borne diseases, and fewer fleas are
observed by pet owners [6]. An added benefit of an effec-
tive residual flea product is its contribution to reproduc-
tive suppression, attempting to kill newly acquired fleas
before they can reach reproductive status [6].
The purpose of the two studies described in this arti-
cle was to evaluate the initial and residual speed of kill
of an imidacloprid + moxidectin topical formulation
against the KS1 Ctenocephalides felis, flea strain infest-
ing cats. The imidacloprid + moxidectin formulation
was compared against a topical selamectin formulation,
which had previously been evaluated against the KS1 cat
flea strain. The KS1 cat flea strain has been maintained
as a closed colony at Kansas State University since 1990.
Previous studies have indicated that the KS1 strain has
some level of resistance or reduced susceptibility to car-
baryl, chlorpyriphos, fenthion, fipronil, imidacloprid,
permethrin, pyrethrins, and spinosad [6-13].
Methods
The two studies conducted in these investigations had
overall similar study designs. The primary difference
between the studies was that in study #1 speed of kill was
evaluated at 24 and 48 hours post-treatment or post-infes-
tation. Whereas in study #2, speed of kill was assessed at
12 and 24 hours post-treatment or post-infestation.
Animals and housing
Study one (1) included the use of 34 purpose bred
Domestic Short Hair cats (17 m:17 f) and study two (2)
used 56 (28 m:28 f) purpose bred DSH cats between 7
and 12 months of age. The cats were housed in standard
stainless steel cages. No drugs, baths, shampoos, or pes-
ticides were administered to the cats during the precon-
ditioning phase or during the course of the study, other
than what was described in the protocol. All animal care
procedures conformed to guidelines established by the
Institutional Animal Care and Use Committee at Kansas
State University (IACUC # 2833 & #2904).
Animal Selection and Randomization
On day -7, cats in each study were infested with 100 cat
fleas, C. felis, (KS1 strain) 1 to 5 days post emergence.
On day -5, flea comb counts were performed to assess
the ability of cats to maintain infestations. Cats were
combed with a fine-toothed flea comb having 12-13
teeth/cm. Flea removal was achieved by combing each
cat thoroughly for 10 min. If five or more fleas were
recovered during this period, the cat was combed for an
additional 5 min. If any fleas were recovered during the
second combing period, the cats were combed for an
additional 5 min.
In study #1 the 15 male cats and 15 female cats
retaining the highest flea levels were retained for the
study. In study #2 the 24 male cats and 24 female cats
retaining the highest flea levels were retained for the
study. Within each gender the cats were ranked in des-
cending order by flea count. Cats were randomly
grouped into replicates of three based on descending
flea counts and allocated into one of three treatment
groups (Study # 1-10 cats; 5 m/5 f: Study # 2-16 cats 8
m/8 f). Each group of cats was then randomly divided
into two subgroups of 5 cats (Study #1) or 8 cats (Study
#2) each. While cats were not allocated according to
weight, the cats in the treatment groups were similar in
size. In study #1 the cats in the three treatment groups
weighed on average 3.27, 3.47 and 3.41 kg. While in
study # 2 the cats in the three treatment groups weighed
on average 3.31, 3.22 and 3.24 kg.
Treatments
In each study, treatment groups were comprised of non-
treated controls, 6%w/v selamectin (Revolution
®;P f i z e r
Animal Health) topical solution, and 10% w/v imidaclo-
prid + 1.0% w/v moxidectin (Advantage Multi
® for
Cats, Bayer Animal Health) topical solution. In both
studies the products were applied according to label
directions.
Efficacy Evaluations
To evaluate efficacy of the formulations in eliminating
an existing flea infestation, all cats were infested with
100 fleas on Day -2 and treatments were applied on Day
0. In study #1, efficacy was determined by removing
fleas from 5 cats in each treatment group at 24 hours,
and 5 cats at 48 hours post-treatment. In study #2, effi-
cacy was determined by removing fleas from 8 cats in
each treatment group at 12 hours, and from 8 cats at 24
hours post-treatment. Residual activity was determined
by reinfesting cats with 100 adult fleas on days 7, 14, 21
and 28 post-treatment and then removing live fleas in
study # 1 from 5 cats in each treatment group at 24
hours and 5 cats at 48 hours post-reinfestation. In study
#2 live fleas were removed from 8 cats in each treat-
ment group at 12 hours and 8 cats at 24 hours post-
reinfestation. Fleas were removed using the previously
described flea combing procedure.
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For both studies, geometric means were calculated fol-
lowing transformation using a logarithmic method (aver-
aging the transformed values, and converting the
average using antilog to represent a geometric mean).
All counts were modified by adding one (1) to each
prior to logarithmic transformation and subtracting one
(1) from the antilog value to meaningfully represent the
geometric mean for each group.
Log (counts+1) were analyzed with an analysis of cov-
ariance (ANCOVA) for each study day where flea
counts were measured. The pre-treatment counts were
used as a covariate. SAS PROC MIXED from SAS ver-
sion 9.2 (SAS
® Institute, Cary, NC) was used for all ana-
lyses. Differences in least square means were determined
between all pair-wise combinations of the three treat-
ment groups. The fixed effect of treatment groups was
evaluated at the alpha level of 0.05.
Results
In study #1, the imidacloprid + moxidectin and the sela-
mectin topical solutions provided 99.8% and 99.0% effi-
cacy within 24 hours of treatment (Table 1). When cats
were reinfested on day 14, both formulations provided ≥
98.3% efficacy within 24 hours post-infestation. On day
28 the efficacy of the selamectin formulation 24 hours
post infestation decreased slightly to 87.1% (Table 1)
while the imidacloprid + moxidectin topical solution
provided 98.9% control. At the 48 hour assessment fol-
lowing the 28 day infestations both formulations pro-
vided ≥ 96.8% efficacy (Table 1).
In study # 2 the imidacloprid + moxidectin topical
solution provided 100% efficacy within 12 hours post-
treatment (Table 2) where as the selamectin topical
solution only provided 69.4% efficacy. Throughout the
next 28 days, both formulations provided similar high
levels of efficacy at the 24 hour post-infestation assess-
ments, with selamectin and imidacloprid + moxidectin
providing reductions of 95.3% and 97.5% efficacy at
the Day 29 count, respectively (Table 2). However,
there were significant differences (P < 0.05) in residual
efficacy at the 12 hour post-infestation assessments at
every time period, with the imidacloprid + moxidectin
formulation providing a more rapid residual speed of
kill (Table 2) when compared to the non-treated con-
trol group and selamectin treated cats. By day 28 post-
treatment, the 12 hour post-infestation efficacy for
selamectin was 57.3%, while the imidacloprid + moxi-
dectin formulation provided a 90.2% reduction in flea
populations.
There were no adverse events associated with treat-
ments in either study.
Discussion
These studies demonstrated that the imidacloprid +
moxidectin topical solution provided rapid initial speed
of kill against the KS1 flea strain, with 100% efficacy
within 12 hours of treatment. However, the initial speed
of kill of selamectin was not quite as rapid. The results
for the initial speed of kill of selamectin in this investi-
gation were similar to results from a 2005 laboratory
study against the KS1 flea strain; in this current investi-
gation the 12 hour post-treatment efficacy was 69.4%
and the 12 hour post-treatment efficacy in the 2005
study was 59.7% [10]. It is unknown why selamectin has
a slower initial speed of kill, but may be related to the
systemic activity of the product and its need to be
absorbed across the skin to reach effective blood levels.
In addition the residual efficacy of selamectin in this
study against the KS1 flea strain was similar to the resi-
dual efficacy observed in the 2005 study [10]. In the cur-
rent investigation the 12 hour post-infestation residual
efficacy assessments efficacy ranged from 99.1% on day
7 to 57.3% on day 28. In the 2005 study, at the same
post-treatment time points, the efficacy was 99.4% and
70.9%. Also in the 2005 study the efficacy observed
when fleas were removed 48 hours after the 28 day
infestation was 99.0%, [10] while in the current investi-
g a t i o nt h ee f f i c a c ya tt h es a me time period was 98.3%.
Additionally, the 24 hour residual efficacy of selamectin
on day 28 in the 2005 study was 90.1%, while in the
current investigation it was 87.1% in study #1 and 95.3%
in study #2. Even though these studies were conducted
over 5 years apart, the efficacy assessments for selamec-
tin against the KS1 fleas strain were remarkably similar.
Also of interest is the difference in residual efficacy
between the imidacloprid + moxidectin topical solution
in this study and the 9.1% w/w imidacloprid formulation
evaluated in the 2005 study. In the previous 2005 speed
of kill study against the KS1 flea strain, the imidacloprid
topical solution did not pro v i d eam o r er a p i dr e s i d u a l
speed of kill at 12 hours post-infestation at 7, 14, 21 or
28 days post-treatment than the selamectin formulation
[10]. While, in this current investigation imidacloprid +
moxidectin topical solution provided a more rapid resi-
dual speed of kill at every 12 hour post-infestation
assessment. In 2005 the 12 hour post-infestation efficacy
at 21 and 28 days for imidacloprid mono topical solu-
tion was 65.2% and 61.6%, respectively [10]. In this cur-
rent investigation the 12 hour post-infestation efficacy at
21 and 28 days for imidacloprid + moxidectin was 98.5%
and 90.2%, respectively.
While direct statistical comparison between the cur-
rent and 2005 study cannot be conducted, it appears
that the imidacloprid + moxidectin formulation provides
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Page 3 of 7Table 1 STUDY #1: Geometric mean flea counts and percent efficacy relative to nontreated controls for cats treated with an 10% w/v imidacloprid + 1.0% w/v
moxidectin topical solution or a selamectin (6% w/v) topical spot-on, 24 and 48 hours after treatment or infestation
Day 0 Day 7 Day 14 Day 21 Day 28
Treatment
1 Mean # of fleas
2,3 % efficacy
4 Mean # of fleas % efficacy Mean # of fleas % efficacy Mean # of fleas % efficacy Mean # of fleas % efficacy
24 hours post-treatment or infestation
Controls 79.2a 67.4a 64.1a 68.6a 52.6a
Selamectin 0.8b 99.0 0.0b 100 1.1b 98.3 6.0b 91.2 6.8b 87.1
Imidacloprid-Moxidectin 0.1b 99.8 0.2b 99.6 0.0b 100 5.4b 92.1 0.6c 98.9
48 hours post-treatment or infestation
Controls 72.7a 69.7a 53.5a 56.8a 52.9a
Selamectin 0.0b 100 0.0b 100 0.0b 100 0.5b 99.1 0.9b 98.3
Imidacloprid-Moxidectin 0.0b 100 0.0b 100 0.1b 99.7 0.6b 99.0 1.7b 96.8
1Each of 5 cats in the control group received no treatment. Each of 5 cats in the 10% w/v imidacloprid + 1.0% w/v moxidectin or selamectin (6%w/v) treatment groups were administered the topical spot-ons,
according to label directions on Day 0.
2Each cat was infested with 100 adult Ctenocephalides felis from the KS1 strain on days -2, 7, 14, 21 and 28.
3Geometric mean # of fleas recovered from cats per treatment group.
4% efficacy = ((geometric mean count control-geometric mean count treatment)/geometric mean count treatment) × 100
a, b, c geometric means within a column with unlike letter superscripts are significantly different (P < 0.05).
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7Table 2 STUDY #2: Geometric mean flea counts and percent efficacy relative to nontreated controls for cats treated with an 10% w/v imidacloprid + 1.0% w/
v moxidectin topical solution or a selamectin (6%w/v) topical spot-on, 12 and 24 hours after treatment or infestation
Day 0 Day 7 Day 14 Day 21 Day 28
Treatment
1 Mean # of fleas
2,3 % efficacy
4 Mean # of fleas % efficacy Mean # of fleas % efficacy Mean # of fleas % efficacy Mean # of fleas % efficacy
12 hours post-treatment or infestation
Controls 52.2a 62.2a 56.4a 47.5a 48.4a
Selamectin 16.0b 69.4 0.6b 99.1 5.3b 90.6 18.6a 60.9 20.6a 57.3
Imidacloprid-Moxidectin 0.0c 100.0 0.0c 100.0 0.2c 99.7 0.7b 98.5 4.7b 90.2
24 hours post-treatment or infestation
Controls 45.1a 56.3a 52.4a 47.1a 49.6a
Selamectin 1.6b 96.4 0.0b 100.0 0.1b 99.7 0.5b 99.0 2.3b 95.3
Imidacloprid-Moxidectin 0.0c 100.0 0.0b 100.0 0.1b 99.8 0.0b 100.0 1.2b 97.5
1Each of 8 cats in the control group received no treatment. Each of 8 cats in the 10% w/v imidacloprid + 1.0% w/v moxidectin or selamectin (6%w/v) treatment groups were administered the topical spot-ons,
according to label directions on Day 0.
2Each cat was infested with 100 adult Ctenocephalides felis from the KS1 strain on days -2, 7, 14, 21 and 28.
3Geometric mean # of fleas recovered from cats per treatment group.
4% efficacy = ((geometric mean count control -geometric mean count treatment)/geometric mean count treatment) × 100
a, b, c geometric means within a column with unlike letter superscripts are significantly different (P < 0.05).
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7a more rapid residual speed of kill against the KS1 flea
strain than imidacloprid mono topical solution. Whether
the more rapid residual speed of kill is from an additive
or synergistic effect of the moxidectin is currently
unknown.
It has previously been demonstrated that several flea
products do not perform well against the KS1 flea
strain either due to resistance or innate reduced sus-
ceptibility [6-13]. It has been demonstrated that the
residual speed of kill of older pyrethroid and organo-
phosphate based flea products is very poor against this
flea strain due to resistance [6,8,11]. In addition more
modern insecticides such as fipronil, imidacloprid, and
spinosad also have reduced activity against the KS1
strain [7,9,10,12,13]. These newer insecticides were
introduced into the U.S. as flea products 6 years (fipro-
nil and imidacloprid) or 17 years (spinosad) after the
KS1 strain was colonized. Various studies using other
cat flea strains have reported that the 28-30 day resi-
dual efficacy of fipronil, imidacloprid, and spinosad
flea products should range from approximately 95% to
100% [7,14-21]. However, when these formulations
were evaluated against the KS1, strain the 28-30 day
residual efficacy was markedly reduced [7,10,12,13].
While these insecticides have reduced residual activity
against the KS1 strain, dinotefuran, metaflumizone and
selamectin topical spot-on formulations have demon-
strated excellent residual efficacy against this strain
[10,12,13,22].
Conclusions
Based on the current studies reported here, the imida-
cloprid + moxidectin combination topical formulation
was highly effective against the KS1 flea strain, with
rapid residual speed of kill, killing 90.2% of fleas within
12 hrs after infestation 28 days post-treatment, and
should provide effective residual flea control on flea
infested cats.
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